News

Johnson Retreats on Demand for Epstein Disclosures, Saying Trump Needs ‘Space’
The Republican speaker of the House had said last week that the government should release “everything” in the Jeffrey Epstein ...
Johnson & Johnson (JNJ): I Counted 15 Separate Surprises,” Says Jim Cramer
We recently published 10 Stocks Jim Cramer Discussed As He Shared Key Insights From Morgan Stanley’s CEO. Johnson & Johnson ...
Josh Johnson joins 'The Daily Show' hosting rotation
Comedy Central announced Josh Johnson will join the News Team hosting rotation at "The Daily Show." Johnson makes his debut ...
Where Bears' Jaylon Johnson ranks among NFL's cornerbacks in 2025
Chicago Bears cornerback Jaylon Johnson has been a cornerstone on defense since he was drafted in the second round of the ...
Johnson & Johnson (JNJ)’s Pasritamig Shows Breakthrough Promise in Prostate Cancer
We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Johnson & Johnson stands second among the most ...
Johnson & Johnson's Healthy 3.3%-Yielding Dividend Is a Very Safe Way to Make Passive Income
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...
Explore more
Johnson & Johnson lifts 2025 forecast, halves tariff cost outlook
Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...
Zacks.com on MSN21h
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.